Clinical difference on the variants and co-mutation in a Chinese cohort with ALK-positive advanced non-small cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical difference on the variants and co-mutation in a Chinese cohort with ALK-positive advanced non-small cell lung cancer

Published:2024-04-18 Issue: Volume: Page:
ISSN:1699-3055
Container-title:Clinical and Translational Oncology
language:en
Short-container-title:Clin Transl Oncol

Author:

Fu Ying,Liu Qing,Wang Xiaohan,Sun Liangchao,Han Xiao^ORCID,Meng Xue^ORCID

Funder

Medical and Health Science and Technology Development Project of Shandong Province

Innovative Research Group Project of the National Natural Science Foundation of China

Science and Technology Support Plan for Youth Innovation of Colleges and Universities of Shandong Province of China

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s12094-024-03481-w.pdf

Reference32 articles.

1. Devarakonda S, Morgensztern D, Govindan R. Genomic alterations in lung adenocarcinoma. Lancet Oncol. 2015;16(7):e342–51. https://doi.org/10.1016/S1470-2045(15)00077-7.

2. Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S, et al. Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer. Nature. 2007;448(7153):561–6. https://doi.org/10.1038/nature05945.

3. Ettinger DS, Wood DE, Aisner DL, Akerley W, Bauman JR, Bharat A, et al. NCCN guidelines insights: non-small cell lung cancer, version 2.2021: featured updates to the NCCN guidelines. J Natl Compr Cancer Netw. 2021;19(3):254–66. https://doi.org/10.6004/jnccn.2021.0013.

4. Tan AC, Pavlakis N. Anti-angiogenic therapy in ALK rearranged non-small cell lung cancer (NSCLC). IJMS. 2022;23(16):8863. https://doi.org/10.3390/ijms23168863.

5. Wang Z, Han Y, Tao H, Xu M, Liu Z, Zhu J, et al. Molecular characterization of genomic breakpoints of ALK rearrangements in non-small cell lung cancer. Mol Oncol. 2023;17(5):765–78.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3